COMMUNIQUÉS West-GlobeNewswire

SPINEWAY : Ajournement de l'Assemblée Générale Mixte du 19 septembre 2019
17/09/2019
Ajournement de l'Assemblée Générale Mixte du 19 septembre 2019 Les actionnaires sont informés que, par délibération en date du 13 septembre 2019, le Conseil d'Administration a décidé d'ajourner la réunion de l'Assemblée [...]
Michael Cole Receives NADP Don Mayes Leadership Award
17/09/2019
National Award Celebrates Volunteer Leadership Spanning Three or More Years DALLAS, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Encouraging a spirit of partnership and collaboration between plans and Dental Service Organizations [...]
Veyonda® and Radiotherapy Profiled at Key Oncology Meeting
17/09/2019
Research relating to Veyonda® in the treatment of advanced prostate cancer is to be included in a key Australian oncology meeting Both Noxopharm and independent investigators have abstracts accepted DARRT-1 interim data [...]
Ear, Nose & Throat Associates Welcomes Dr. Leanna-Marie Robertson
17/09/2019
TOWSON, Md., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Ear, Nose & Throat Associates , a division of Centers for Advanced ENT Care, is excited to announce that Dr. Leanna-Marie Robertson will be joining our team of [...]
Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer
17/09/2019
Shea’s 30-Year Diverse Experience in Acquisitions, Capital Markets, SEC Reporting, and Leading Financial Organizations Bolsters PBI’s Strong Senior Management Team South Easton, MA, Sept. 17, 2019 (GLOBE NEWSWIRE) -- [...]
Beroni USA is Ready to Commercialise a Diagnostic Kit for Detecting Zika, Dengue, Chikungunya and West Nile Viruses Worldwide
17/09/2019
NEW YORK and SYDNEY, Australia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (“Beroni’ or the “Company”) entered into an agreement with the Columbia University, New York (“Columbia University”) in March 2018 [...]
INmune Bio Invited to Speak on Company’s Advancements in Cancer Treatments at the Targeting Innate Immunity Congress and MarketsandMarkets Next Gen Immuno-Oncology Congress
17/09/2019
La Jolla, CA., Sept. 17, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Leanne Ebert Murphy Joins Comprehensive Pharmacy Services as Executive Vice President and General Counsel
17/09/2019
Strategic Legal Advisor with extensive Commercial and Health Law Experience MEMPHIS, Tenn., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Comprehensive Pharmacy Services, LLC (CPS), the nation’s largest hospital pharmacy services [...]
InnovaHealth Partners Invests in Koelis, a Leader in Prostate Cancer Diagnostics and Treatment
17/09/2019
NEW YORK, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Koelis SAS (“Koelis” or the “Company”) and InnovaHealth Partners, LP (“InnovaHealth”) jointly announced today along with Medevice Partners (“Medevice”) that InnovaHealth has [...]
Les partenaires d'InnovaHealth investissent dans Koelis, un leader du diagnostic et du traitement du cancer de la prostate
17/09/2019
NEW YORK, 17 sept. 2019 (GLOBE NEWSWIRE) -- Koelis SAS (« Koelis » ou « la Société ») et InnovaHealth Partners, LP (« InnovaHealth ») ont annoncé aujourd'hui conjointement avec Medevice Partners (« Medevice ») qu' [...]
Rafael Pharmaceuticals Announces Expansion into France of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613®️ (devimistat) in Combination with Modified FOLFIRINOX as First-Line Treatment for Patients with Metastatic Pancreatic Cancer
17/09/2019
CRANBURY, N.J., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced the expansion of its [...]
The Delta Companies Named One of the Largest Staffing Firms in the U.S. by SIA
17/09/2019
As healthcare staffing demand ramps up, the firm continues on a steady growth trajectory DALLAS, Sept. 17, 2019 (GLOBE NEWSWIRE) -- The Delta Companies (TDC) , a leading staffing firm for healthcare professionals [...]
Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (Keytruda®) for the Treatment of Triple Negative Breast Cancer
17/09/2019
MIRAMAR, Fla., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that the NSABP Foundation, Inc. (NSABP [...]
AXIM® Biotechnologies Announces Cultivation Agreement to Establish Company’s First Domestic Industrial Hemp Source & Begins Harvesting
17/09/2019
SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that it has [...]
athenahealth Names Luis Borgen Chief Financial Officer
17/09/2019
With 22 Years of Experience, Borgen Joins Healthcare IT Leader’s Executive Team to Drive Continued Growth WATERTOWN, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled [...]
CV Sciences, Inc. Wins 2019 NEXTY Award
17/09/2019
Company’s industry-dominating hemp extract brand, PlusCBD Oil™ , wins Consumer Choice Award at Natural Products Expo East SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV [...]
Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™
17/09/2019
SOLANA BEACH, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has [...]
Avricore Health and Clinart MENA Announce Interim Agreement for HealthTab™ + RASTR Network Middle East Expansion
17/09/2019
VANCOUVER, British Columbia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") is pleased to announce that it has signed a first stage agreement in the [...]
Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding
17/09/2019
WESTLAKE VILLAGE, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that it has elected to file a voluntary petition to [...]

Pages